Stockholders' Equity - Warrants (Details) - $ / shares |
12 Months Ended | |||
---|---|---|---|---|
Dec. 31, 2017 |
Dec. 31, 2019 |
Dec. 31, 2018 |
Mar. 29, 2019 |
|
Class of Warrant or Right [Line Items] | ||||
Warrant exercise price (in dollars per share) | $ 3.47 | |||
Warrants | ||||
Class of Warrant or Right [Line Items] | ||||
Warrants received, as a percentage of common shares purchased | 25.00% | |||
Warrants outstanding, beginning | 5,210,698 | 5,253,318 | ||
Warrants granted | 288,184 | 0 | ||
Warrants exercised | (93,213) | (42,620) | ||
Warrants outstanding, ending | 5,253,318 | 5,405,669 | 5,210,698 | |
Warrant exercise price (in dollars per share) | $ 8.28 | $ 8.20 | $ 8.32 | |
Warrant exercise price, grants during the period (in dollars per share) | 3.47 | 0.00 | ||
Warrant exercise price, exercised during the period (in dollars per share) | $ 0.00 | $ 4.25 | ||
Warrants outstanding, remaining contractual life | 3 years 10 months 21 days | 2 years 4 months 24 days | 3 years 1 month 6 days | |
Warrants granted, remaining contractual life | 9 years 3 months |
X | ||||||||||
- Definition The percentage of common shares purchased that investors received in warrants or rights. No definition available.
|
X | ||||||||||
- Definition The number of warrants or rights exercised during the period. No definition available.
|
X | ||||||||||
- Definition The number of warrants or rights granted during the period. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants that were exercised during the period. No definition available.
|
X | ||||||||||
- Definition Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants that were granted during the period. No definition available.
|
X | ||||||||||
- Definition The weighted average remaining contractual life for warrants outstanding. No definition available.
|
X | ||||||||||
- Definition The weighted average remaining contractual life for warrants granted during the period. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Definition Number of warrants or rights outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Details
|